Insmed Inc (INSM)
73.15
-0.66
(-0.89%)
USD |
NASDAQ |
Nov 22, 16:00
73.10
-0.05
(-0.07%)
Pre-Market: 20:00
Insmed Cash from Investing (Quarterly): -1.003B for Sept. 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.003B |
| June 30, 2024 | -6.783M |
| March 31, 2024 | 295.32M |
| December 31, 2023 | 1.803M |
| September 30, 2023 | 7.147M |
| June 30, 2023 | -274.16M |
| March 31, 2023 | 41.60M |
| December 31, 2022 | 20.31M |
| September 30, 2022 | 49.42M |
| June 30, 2022 | -2.904M |
| March 31, 2022 | -101.41M |
| December 31, 2021 | -51.22M |
| September 30, 2021 | -8.401M |
| June 30, 2021 | -3.485M |
| March 31, 2021 | -1.181M |
| December 31, 2020 | -1.515M |
| September 30, 2020 | -0.747M |
| June 30, 2020 | -1.881M |
| March 31, 2020 | -2.679M |
| December 31, 2019 | -13.04M |
| September 30, 2019 | -14.59M |
| June 30, 2019 | -10.61M |
| March 31, 2019 | -4.028M |
| December 31, 2018 | -4.751M |
| September 30, 2018 | -1.851M |
| Date | Value |
|---|---|
| June 30, 2018 | -2.847M |
| March 31, 2018 | -5.365M |
| December 31, 2017 | -1.70M |
| September 30, 2017 | -0.447M |
| June 30, 2017 | -0.437M |
| March 31, 2017 | -0.417M |
| December 31, 2016 | -0.772M |
| September 30, 2016 | -1.30M |
| June 30, 2016 | -1.54M |
| March 31, 2016 | -0.588M |
| December 31, 2015 | -0.407M |
| September 30, 2015 | -0.853M |
| June 30, 2015 | -0.93M |
| March 31, 2015 | -1.264M |
| December 31, 2014 | -1.527M |
| September 30, 2014 | -2.919M |
| June 30, 2014 | -0.564M |
| March 31, 2014 | -0.331M |
| December 31, 2013 | -0.113M |
| September 30, 2013 | 1.933M |
| June 30, 2013 | -0.33M |
| March 31, 2013 | -0.161M |
| December 31, 2012 | 44.59M |
| September 30, 2012 | -0.028M |
| June 30, 2012 | 4.12M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-1.003B
Minimum
Sep 2024
295.32M
Maximum
Mar 2024
-52.86M
Average
-2.28M
Median
Cash from Investing (Quarterly) Benchmarks
| Alnylam Pharmaceuticals Inc | -30.25M |
| Amicus Therapeutics Inc | 34.27M |
| Collegium Pharmaceutical Inc | -248.96M |
| enVVeno Medical Corp | 6.22M |
| Fulcrum Therapeutics Inc | 4.35M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -180.92M |
| Cash from Financing (Quarterly) | 397.20M |
| Free Cash Flow | -636.03M |
| Free Cash Flow Per Share (Quarterly) | -1.063 |
| Free Cash Flow to Equity (Quarterly) | 31.84M |
| Free Cash Flow to Firm (Quarterly) | -163.45M |
| Free Cash Flow Yield | -5.59% |